Quantum Operation Inc., a Tokyo-based healthcare IoT startup, will present the world’s first noninvasive glucometer in the form of a wristband that is capable of nonstop monitoring. The device, which uses the company’s patented spectrum sensing technology to accurately measure glucose in a person’s bloodstream through the skin, eliminates the need -- and pain -- of daily needle use for diabetic patients. The company is also adding a new function to the device to monitor changes in pre- and post-meal blood glucose levels -- an important indicator for diabetic patients to keep track of to prevent progression of the disease.
Quantum Operation Inc., a Tokyo-based healthcare IoT startup, will present the world’s first noninvasive glucose monitor that is capable of truly continuous measurement. The company’s patented spectrum sensing technology enables the monitoring sensor to accurately measure glucose in a person’s bloodstream through the skin while being worn around their wrist. This monitor eliminates the need - and pain - of daily needle uses for diabetic patients. During CES, Quantum Operation will also showcase its oxygen saturation measuringsensor (SpO2) that can be worn around the wrist.